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INTRODUCTION 
Human Immunodeficiency Virus 
(HIV) is a retrovirus and belongs to the 
lentivirus family 1-5. The HIV was first 
identified in 1983 and was shown to be 
the cause of Acquired Immune 
Deficiency Syndrome (AIDS) in 1984. 
HIV infection is characterized by the 
depletion of the CD4 + helper/ inducer 
subset of T-lymphocytes, leading to 
severe immune deficiency, constitutional 
symptoms, neurological diseases, and 
opportunistic infections and neoplasm 
(reviewed in Fauci and Lane)1. Two 
genetically different but related forms of 
HIV, called HIV-1 and HIV-2, have been 
isolated from patients with AIDS. HIV-1 
is found worldwide and is responsible 
for the worldwide pandemic, and HIV-2, 
found mainly in West Africa, 
Mozambique, and Angola. HIV-2 is less 
pathogenic and makes little or no 
contribution to paediatric AIDS; 
therefore, all discussion in this seminar 
refers to HIV-1. HIV-1 has been divided 
into other sub types based on the 
genetic analysis constituent of M (Major) 
and O (Outliers); hence there are sub-
groups or sub-types A, B, C, D, E. The 
following subtypes are seen in Africa: A 
and D (East and Central), C (Southern 
Africa in over 90% of cases), and A 
recombinants (West Africa). Subtype C 




Epidemiology of HIV Infection/ 
Burden of the Disease 
Magnitude of Paediatric HIV/AIDS in 
Sub-Saharan Africa 
At the end of 2003, 40 million people 
were living with HIV worldwide. 2.1 
million were children within fifteen years. 
Over 600,000 new cases are reported 
per year. Prevalence of HIV in mothers 
attending Antenatal clinic is 4.1% in 
Nigeria. In Benin 5.3% are infected with 
HIV, and majority of childhood infection 
is via mother to child (MTCT). Children 
under age 15years make up 10% of the 
total HIV-positive population hence the 
need for the best available prevention, 
care and treatment 7. The four principles 
of the Rights of the Child (CRC) must be 
taken into account; right to life, survival 
and development, right to be treated 
equally, right to participate in activities 
and decisions that affect them and all 
actions should be based on the “best 
interest” of the child. 
Distinguishing Characteristics between 
Adults and Children HIV/AIDS 
Transmission modes are usually 
different- MTCT is the predominant 
mode of transmission (>95%).  This may 
be during pregnancy (5-10%), labour/ 
delivery (10-20%), breast feeding (5-
20%). Latency period is shorter in 
children.  Children’s immune systems are 
particularly prone to destruction thus 
leading to increase viral loads in 
paediatrics 6-10. Body surface area-
based dosing that change over time in 
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paediatrics. It is important to note that 
the CD4 count tends to be higher in 
children and it is not as reliable a tool as 
in adult. CD4 percentage is much more 
useful and in infants less than 12 
months of age, neither CD4 count nor 
percentage is predictive of 
Pnuemocystic carinae pneumonia risk 6, 
8-9. 
HIV Disease Progression and Outcome 
HIV disease is more aggressive than 
in adult. Overall MTCT rates without 
interventions are approximately 30-45%. 
Untreated pediatric AIDS will die by the 
2nd birthday. The natural history of 
perinatally infected children fits into one 
of three categories: 
Rapid progressors who die by age of 
1 year (about 25-30%) with onset and 
symptoms of AIDS within the first few 
months of life, median survival age 6-9 
months and infections usually in-utero. It 
often coincide with the period of initial 
expansion of CD4 cells, aided by the 
normal movement of these cells in to the 
bone marrow, spleen and thymus 
resulting in efficient dissemination of the 
virus (Median value 750,000 copies/uL). 
Most of the patients have a positive HIV 
culture and/or detectable virus in plasma 
in the 1st 48 hours of life and the viral 
load rapidly increases, peaks at 2-3 
months of age. Children who develop 
symptoms early in life and death by 3-5 
yrs of age (50-60%) usually acquired the 
infection perinatally. They have much 
slower disease progression than the 
rapid progressors.  Survival time age of 
6 years and the viral load increases by 
2-3 months of age (median Value of 
100,000 copies/uL). Within the next 24 
months there is a decline in the viral 
load. Long term survivors live beyond 
age 8yrs (5-25%). They usually acquired 
the infection perinatally and they have 
minimal or no disease progression. 
They have a relatively normal CD4 cells 
with a very low viral load for up to or 
even more than 8 years 9-11. The rate of 
downhill progression is dependent on 
the level of care, nutrition, and 
concomitant infection (example TB). 
Complications of HIV Infection in 
Children 
Pulmonary Conditions in HIV 
Pneumonia and chronic lung 
diseases contribute to the increased 
morbidity and mortality of HIV-infected 
children. Most children present with 
recurrent bacterial pneumonias, but in 
children less than 1 year of age PCP 
also contributes to the high infant 
mortality. 
Pulmonary conditions complicating 
HIV in children include: 
TB-HIV Co-infection 
The HIV pandemic has led to a 
resurgence of TB in both adults and 
children. Children also have an 
increased risk of developing primary 
progressive TB because of the associated 
severe immune suppression resulting 
from their young age and HIV. 
Extrapulmonary TB is seen more often 
in HIV-infected children. There is a 
higher case fatality rate for children who 
are co-infected with TB and HIV. The 
reported seroprevalence of HIV in 
children with TB ranges from 10 to 60% 
(Most common in South Africa and 
Nigeria). Nigeria has the 4th largest TB 
and 3rd largest HIV infection worldwide. 
In UBTH: 20% of those with HIV have 
PTB (Sadoh and Oviawe) 6-7.  
Diagnosing TB in children was difficult 
even before the HIV/AIDS pandemic; 
now it is more difficult because an HIV-
positive child may have many other 
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pulmonary conditions and HIV-related 
chronic lung diseases that mimic the 
symptoms of TB. Most TB diagnostic 
criteria (chronic symptoms, smear positive 
contact, positive Mantoux, response to 
treatment) have lower sensitivity and 
specificity in a co-infected child than in a 
non-HIV-infected child.  
Treating TB IN Children 
In most instances treatment of TB is 
usually presumptive because it is 
difficult to make an etiological diagnosis. 
In treating children who are co-infected 
with HIV and TB, use national guidelines 
Challenges in Management TB-HIV 
Co-infection 
Rifampicin may interact with NNRTI 
and PI drugs. These drugs have similar 
routes of metabolism and elimination 
(cytochrome P450 enzyme pathway). 
Extensive drug interactions may result in 
sub-therapeutic drug levels. Preferred 
first line is triple NRTI- ABC/ 3TC/AZT. 
EFV may also be used to replace NVP 
in standard first line. EFV not 
recommended in children < 3yrs of age 
(causes hallucinations, nightmare day 
dreaming). Standard first line may also 
be used (if possible after anti-TB 
therapy) 12. 
 
Immune Reconstitution Syndrome in 
the Context of Co-therapy 
This is the paradoxical clinical 
deterioration after starting HAART, 
resulting from improved immune system 
interaction with organisms (TB, PCP, 
CMV, Herpes, cryptococcus, candida, 
aspergillosis) that have colonised the 
body during early stages of the disease. 
Commonly observed in patients 
receiving anti-TB who were initiated on 
ART. Usually occur within few weeks of 
commencement of ART. Patients usually 
have very low CD4 counts. Seen mainly 
in adults but also in children. Characterized 
by worsening disease after initial 
improvement with new onset of systemic 
symptoms especially: Fever, worsening 
pulmonary infiltrates, pulmonary effusion, 
Development of peripheral and mediastinal 
lymphadenopathy, and Expanding CNS 
lesions in tuberculomas 12. 
Generally, may be self-limiting – 
lasts 10-40 days. If severe, requires 
short course glucocorticoids: Prednisone 
1-2 mg/kg/d X 1-2 weeks.  Prevention is 
to start TB therapy first. 
Pneumocystis jiroveci pnuemonia 
Pneumocystis pneumonia (PCP) is 
caused by a fungus called pneumocyctis 
jiroveci (formerly called pneumocystis 
carinii). PCP is a major cause of severe 
pneumonia (15–30%) and death (30–
50%) in HIV-infected infants. Infants are 
usually in a good nutritional state and 
may not have clinical features that 
indicate the presence of HIV/AIDS. The 
incidence of PCP is highest during the 
first year of life and usually peaks at 3 to 
6 months of age though it can occur 
after 1 year of age, but with decreasing 
frequency 6. 
Clinical Features of PCP include Low-
grade fever or may be afebrile, marked 
respiratory distress (chest in-drawing, 
cyanosis, inability to drink). On 
auscultation, the chest is clear or 
diffuses fine crepitations. There is a 
poor response to standard antibiotic 
treatment. 
Investigations include Sputum induction 
with nasophyaryngeal aspirates or 
bronchoalveolar lavage may help in 
diagnosing PCP and this is a big 
challenge in this region. There are no 
radiological changes specific to PCP. In 
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cases where a definitive diagnosis of 
PCP cannot be made, but where there 
is a high index of suspicion of PCP, 
therapy must be initiated promptly, 
along with treatment for bacterial 
pneumonia.  Management of PCP 
include supportive- fluid therapy, use of 
paracetamol for pain; and then specific 
which include give intravenous high 
dose cotrimoxazole (CTZ) 20 mg/kg of 
trimethoprim per day OR 80 mg/kg/day 
of sulphamesoxazole given every 6 
hours for 21 days. Give the same dose 
orally if IV preparations are not available. 
Add prednisone at 2 mg/kg/day for 7 to 
14 day if child is in severe respiratory 
distress (taper if treatment >7days). 
Other treatment modalities include 
Dapsone (>1 month), Pentadimine (> 5 
yrs), Atovaquine 6.  
Neurologic Complications of HIV Infections 
in Children 
Neurological manifestations are some of 
the most common modes of presentation 
of HIV/AIDS, but they are infrequently 
diagnosed in children. Delay in reaching 
developmental milestones, in particular, 
may be an early indication of HIV 
infection in HIV-exposed children.  HIV 
encephalopathy is a neurologic dysfunction 
arising from direct HIV infection of the 
brain. 
HIV Encephalopathy 
Growth and development of the brain 
is outwardly manifested by achievement 
of childhood milestones (smiling, walking, 
talking, etc.). HIV infection of the brain 
interferes with this process and 
manifests as static, slowing, or 
regression of developmental milestones 
or as localized damage. This whole 
process is referred to as HIV 
encephalopathy. Age of onset of 
developmental delay is unpredictable, 
but the onset of encephalopathy may be 
related to the presence of other 
symptoms of HIV disease (e.g., 
hepatosplenomegaly and lymphadenopathy). 
HIV encephalopathy has been reported 
to be about 21% in HIV infected African 
children. 7.4% of children with HIV over 
a 6-year period in UBTH had HIV 
encephalopathy (Sadoh, Okunola and 
Oviawe, 2006)7. 
Diagnosis is mainly clinical and 
depends on the presence of at least two 
of the following, for at least 2 months, in 
the absence of other identifiable cause, 
failure to attain or loss of developmental 
milestones or loss of intellectual ability. 
Decline in cognitive functions as verified 
by standard developmental scale or 
neuropsychological tests, behavioural 
changes, impaired brain growth or 
acquired microcephaly and acquired 
symmetrical motor deficit manifested by 
two or more of the following: paresis, 
pathologic reflexes, ataxia, or gait 
disturbances are other signs of HIV 
encephalopathy. 
Challenges in Management of HIV 
Encephalopathy Include poor health 
seeking behaviours, preference to 
tradomedical or church care, and 
unaffordable cost of hospital services 
means patients commonly come to the 
hospital at advanced stage of the 
disease. Others include long hospital 
stay (mean=9.3 ±2.7 weeks) due to 
morbidity of the disease and then lack 
fund to pay the huge hospital bills. 
Advanced stage of the disease and lack 
of HAART contribute to high mortality 
rate (80% in the study in UBTH). 
Malnutrition 
Childhood malnutrition is high among 
HIV-infected children and the magnitude 
is even higher in developing countries, 
where it is already endemic. HIV-
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infected children are at increased risk of 
malnutrition for many reasons, including: 
decreased food intake because of 
anorexia associated with illness, mouth 
ulcers, and oral thrush. Increased 
nutrient loss resulting from malabsorption, 
diarrhoea, HIV enteropathy, increased 
metabolic rate because of infections, 
opportunistic infections, and the HIV 
infection itself. Release of cytokines 
(TNF alpha, cachetin) into plasma or 
tissues may mediate weight loss in HIV-
infected children. The effects of 
malnutrition are compounded by the 
high burden and recurring infections and 
infestations in HIV-infected children. In 
addition, HIV-positive mothers have 
higher rates of low-birth-weight babies 
and premature birth, which are risk 
factors for malnutrition. Characteristics 
of HIV-infected children associated with 
malnutrition include: Micronutrient 
deficiencies (low serum levels of zinc, 
selenium, vitamins, A, E, B6, B12 and 
C) are common among HIV-infected 
children, reduce immunity, and 
predispose them to more infections and 
worsening nutritional status 11-14.  
Challenges in Management of Paediatrics 
HIV/AIDS 
Prevention of MTCT of HIV 
Health seeking challenges -more 
pregnant women need VCT. Other 
challenges include infant feeding 
problems either as prolonged breastfeeding 
culture and /or mixed feeding problems. 
Transmission rate is 3% in UBTH 
(unpublished data). Thanks to PEPFAR, 
GON etc 7-8. 
Diagnosis: Challenges include 
stigmatization, sero-discordant couples, 
and disruption of family unit, screening 
of other sibling and disclosing diagnosis 
to the child. 
 
 
Treatment of HIV in Children-Challenges 
Fewer medicines are available in 
paediatric formulations (Problem with 
dosage and compounding the drugs). 
The drug intake may affect future height 
of child in addition to weight. Change in 
dosage with change in weight of the 
child, developmental issues are critical 
in paediatrics, and adherence issues 
pose more challenges in management 
of paediatrics AIDS. Parent/caregiver 
must remember to give the drug; the 
child may not take the drug because of 
stubbornness or bad taste multiple 
caregivers may not communicate well 
concerning the drugs. There may be 
overdose of the child and the child may 
run out of drugs faster. There may be an 
assumption that another caregiver has 
already dispensed the drug.  
Most importantly when to disclose to the 
child his/her HIV status and the consent 
on why he/she is taking the medicine.  
Drug side effect is another challenge. 
Zidovudine causes anaemia, Nevirapine – 
Hepatotoxicity,  Efavirenz causes day 
dreaming, night mares, hallucinations in 
children less than 3 years old There is 
the  problem with dosing (Doses in 
surface area)  as well as problem with 
refrigeration especially stavudine. 
HIV/AIDS Orphans 
In Nigeria, AIDS orphans are on the 
increase. In 2003, 1 million AIDS orphan 
and the death of parents living with 
HIV/AIDS and the changing socioeconomic 
outlook may affect the number of AIDS 
orphan and their care. In UBTH, 13.7% 
were AIDS orphans (An 8 year review of 
children with HIV 1996-2003) – Sadoh 
et al. (2005) with a mean age of 49 ± 
35.4 months and majority were under 
fives. Most had stopped schooling and 
childhood vaccination because of illness. 
Death rate was 78.6% and this shows an 
urgent need for the government and 
NGOs to attend to rising AIDS orphan 
problem in Nigeria. 
Recommendations include; dose 
children appropriately and prevent HIV 
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Infection in women of child bearing age. 
This is the best way to prevent 
transmission in children, strengthen 
antenatal care services and encourage 
increased attendance. Develop and 
promote voluntary and confidential 
counselling and HIV testing services. 
Intense implementations of PMTCT 
programme and make them more 
widespread, and then strengthened 
family planning services including 
involvement of males in family planning 
services. 
In conclusion, Children are not adults 
in smaller doses! Emergence of HIV 
threatens to reverse the gains in child 
survival strategy. Challenges in 
Paediatrics HIV/AIDS management are 
enormous and therefore all hands must 
be on deck in eradicating this bug 
especially as it relates to our children. 
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